(RTTNews) - InnovAge Holding Corp. (INNV), a provider of comprehensive healthcare programs, announced the pricing of a secondary offering of its common stock by selling stockholders.

Investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe are offering 10 million shares at $9.25 per share.

The selling stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares at the public offering price, after deducting underwriting discounts and commissions.

InnovAge will not sell shares in the offering or receive any proceeds from the transaction.

The company will bear the costs associated with the sale, excluding underwriting discounts and commissions.

The offering is expected to close on September 24, 2026, subject to customary closing conditions.

As of June 30, 2026, InnovAge had $141.34 million in cash, cash equivalents, restricted cash, and short-term investments.

INNV closed Tuesday's trade at $10.66, up 0.52%.

In the overnight market, shares are down 7.56% at $9.85.